LEARNING OBJECTIVES:
• Discuss strategies for how healthcare organizations are coping with and overcoming drug shortages
• Understand and recognize challenges within the healthcare industry related to drug shortages and potential sourcing solutions to support a resilient supply chain
• Gain knowledge on how to collaborate within the healthcare community to address drug shortages
• Describe supply chain challenges and successes during the COVID-19 pandemic learning from various industry stakeholders
CO-SPEAKERS:
STACY LAUDERDALE
Stacy Lauderdale is the Senior Director of Drug Information at Vizient. During her 14 years with the Vizient family of companies, Stacy has been responsible for the oversight and development of clinical pharmacy resources including formulary resources, pharmacy communications, expert panels, and education. In 2018, in collaboration with the Vizient Pharmacy Clinical Council, she created a member drug shortage group that prepares drug shortage mitigation strategies with a focus on developing strategies for essential medications. Prior to joining Vizient, she worked for several years in academia and provided drug information services to multiple health systems.
DOUG KUCERA
Doug Kucera is Associate Vice-President, Contract Services at Vizient. During his 14 years with the organization, Doug has managed and led strategic sourcing for several pharmacy product and service categories. Most recently, Doug led the formation of Novaplus Enhanced Supply, in support of Vizient’s mission to end drug shortages. Doug has served on the Vizient Drug Shortages Task Force Executive Committee—and is a participant in the End Drug Shortages Alliance. Prior to joining Vizient, Doug worked in strategic research, pricing, & compliance positions in other industries. Doug has BS and BA degrees in international business and Spanish from the University of Nebraska-Lincoln.
Latest Videos
View all Videos
Terry Terify, the Chief Commercial Officer of Azurity Pharmaceuticals, shares insights about the company's mission to serve overlooked patient populations. With nearly three decades of experience in the pharmaceutical industry, Terry highlights Azurity's focus on developing dosage formulations for pediatric, adult, and geriatric patients with unmet needs. The company boasts a diverse portfolio of 22 promoted products across six therapeutic categories, including oncology and cardiovascular.
Valerie Hoffman is the Associate Marketing Director at Long Grove Pharmaceuticals. Valerie prioritizes drug safety and aims to enhance it through clear, distinctive labeling. She also emphasizes open communication in leadership and works to build strong customer relationships.